SC
SPRB

Steven Cohen’s Spruce Biosciences SPRB Stock Holding History

Steven Cohen’s Portfolio SPRB Stock Details SPRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.53M Buy
+28,278
New +$1.58M ﹤0.01% 2562

Other funds holding SPRB

ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $4.66B AUM 77.16% 1-Year Est. Return

Steven Cohen's SPRB Position: Q2 2026 in Review

Steven Cohen opened a new position in Spruce Biosciences (SPRB) in Q2 2026: 28,278 shares worth $1.53M. The stake represents ﹤0.01% of the portfolio and ranks #2562 among its holdings.

63 funds tracked by Wall St. Rank hold SPRB as of Q2 2026.

  • Steven Cohen held 28,278 shares of Spruce Biosciences worth $1.53M as of Q2 2026.
  • Spruce Biosciences was a new Steven Cohen position in Q2 2026.
  • Spruce Biosciences made up ﹤0.01% of Steven Cohen's portfolio in Q2 2026, its #2562 holding.
  • 63 funds tracked by Wall St. Rank held Spruce Biosciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.